XML 24 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Cumulative Effect, Period of Adoption, as Adjusted
Common Stock
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, as Adjusted
Retained Earnings
Treasury Stock
Cumulative Effect, Period of Adoption, as Adjusted
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, as Adjusted
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, as Adjusted
Total
Balance at Dec. 31, 2017   $ 672,593     $ 1,516,957   $ (435,178)   $ (50)     $ 1,754,322
Balance (in shares) at Dec. 31, 2017   80,398         (28,644)          
Increase (Decrease) in Stockholders' Equity                        
Net income (loss)         280,372             280,372
Net unrealized appreciation on marketable securities, net of tax                 18     18
Exercise of common stock options and vested restricted stock units   $ 2,174                   2,174
Exercise of common stock options and vested restricted stock units (in shares)   780                    
Shares acquired from vested employee stock awards for income tax withholdings             $ (13,556)         (13,556)
Shares acquired from vested employee stock awards for income tax withholdings (in shares)             (239)          
Sale of common stock under employee stock purchase plan   $ 3,038                   3,038
Sale of common stock under employee stock purchase plan (in shares)   61                    
Stock based compensation expense   $ 13,105                   13,105
Treasury stock purchases             $ (54,448)         (54,448)
Treasury stock purchases (in shares)             (968)          
Cash dividends declared         (20,744)             (20,744)
Balance at Dec. 31, 2018 $ 690,910 $ 690,910 $ (13,141) $ 1,763,444 1,776,585 $ (503,182) $ (503,182) $ (32) (32) $ (13,141) $ 1,951,140 1,964,281
Balance (in shares) at Dec. 31, 2018 81,239 81,239       (29,851) (29,851)          
Increase (Decrease) in Stockholders' Equity                        
Net income (loss)         340,099             340,099
Net unrealized appreciation on marketable securities, net of tax                 $ 32     32
Exercise of common stock options and vested restricted stock units   $ 3,106                   3,106
Exercise of common stock options and vested restricted stock units (in shares)   707                    
Shares acquired from vested employee stock awards for income tax withholdings             $ (9,313)         (9,313)
Shares acquired from vested employee stock awards for income tax withholdings (in shares)             (173)          
Sale of common stock under employee stock purchase plan   $ 3,165                   3,165
Sale of common stock under employee stock purchase plan (in shares)   65                    
Stock based compensation expense   $ 5,770                   5,770
Common stock purchased and cancelled   $ (16,145)                   (16,145)
Common stock purchased and cancelled (in shares)   (268)                    
Treasury stock purchases             $ (78,476)         (78,476)
Treasury stock purchases (in shares)             (1,396)          
Cash dividends declared         (24,364)             (24,364)
Balance at Dec. 31, 2019 $ 686,806 $ 686,806 $ (11,639) $ 2,067,540 2,079,179 $ (590,971) $ (590,971)     $ (11,639) $ 2,163,375 2,175,014
Balance (in shares) at Dec. 31, 2019 81,743 81,743       (31,420) (31,420)          
Increase (Decrease) in Stockholders' Equity                        
Net income (loss)         (8,515)             (8,515)
Exercise of common stock options and vested restricted stock units   $ 38                   38
Exercise of common stock options and vested restricted stock units (in shares)   287                    
Shares acquired from vested employee stock awards for income tax withholdings             $ (6,165)         (6,165)
Shares acquired from vested employee stock awards for income tax withholdings (in shares)             (108)          
Sale of common stock under employee stock purchase plan   $ 2,781                   2,781
Sale of common stock under employee stock purchase plan (in shares)   65                    
Stock based compensation expense   $ 6,802                   6,802
Treasury stock purchases             $ (20,000)         (20,000)
Treasury stock purchases (in shares)             (386)          
Cash dividends declared         (7,019)             (7,019)
Warrants issued under CARES Act agreements   8,248                   8,248
Balance at Dec. 31, 2020   $ 704,675     $ 2,052,006   $ (617,136)         $ 2,139,545
Balance (in shares) at Dec. 31, 2020   82,095         (31,914)